环球中医药
環毬中醫藥
배구중의약
GLOBAL TCM
2015年
8期
897-900
,共4页
刘迎新%邹大威%耿建国%高彦彬%尚雅文%李娇阳%龚慕辛%彭麒朕
劉迎新%鄒大威%耿建國%高彥彬%尚雅文%李嬌暘%龔慕辛%彭麒朕
류영신%추대위%경건국%고언빈%상아문%리교양%공모신%팽기짐
糖尿病肾病%糖肾宁%KK-Ay小鼠%血小板衍生生长因子%血小板衍生生长因子受体
糖尿病腎病%糖腎寧%KK-Ay小鼠%血小闆衍生生長因子%血小闆衍生生長因子受體
당뇨병신병%당신저%KK-Ay소서%혈소판연생생장인자%혈소판연생생장인자수체
Diabetic nephropathy%Tangshenning%KK-Ay mice%Platelet-derived growth factor%Platelet-derived growth factor receptor
目的:观察糖肾宁对自发性2型糖尿病 KK-Ay小鼠肾组织血小板衍生生长因子( platelet-derived growth factor, PDGF )、血小板衍生生长因子受体( platelet-derived growth factor receptor,PDGFR)蛋白表达的影响。方法采用自发性2型糖尿病KK-Ay小鼠建立糖尿病肾病模型,随机分为模型组、缬沙坦组和糖肾宁组各20只,设立C57BL/6J小鼠20只为空白组;药物干预12周后,测定24小时尿微量白蛋白排泄率( urinary albumin excretion, UAER),Masson染色观察各组肾脏病理,Western Blot检测PDGF、PDGFR蛋白表达水平。结果与空白组比较,模型组24小时UAER明显升高(P<0.05),肾组织PDGF、PDGFR蛋白表达明显升高;与模型组比较,缬沙坦组和糖肾宁组24小时UAER均有不同程度的降低(P<0.05),给药组间无显著性差异(P>0.05),肾组织PDGF、PDGFR蛋白表达有不同程度降低(P<0.05)。结论糖肾宁能够降低自发性2型糖尿病KK-Ay小鼠24小时UAER,抑制PDGF及PDGFR蛋白的过度表达,保护肾功能。
目的:觀察糖腎寧對自髮性2型糖尿病 KK-Ay小鼠腎組織血小闆衍生生長因子( platelet-derived growth factor, PDGF )、血小闆衍生生長因子受體( platelet-derived growth factor receptor,PDGFR)蛋白錶達的影響。方法採用自髮性2型糖尿病KK-Ay小鼠建立糖尿病腎病模型,隨機分為模型組、纈沙坦組和糖腎寧組各20隻,設立C57BL/6J小鼠20隻為空白組;藥物榦預12週後,測定24小時尿微量白蛋白排洩率( urinary albumin excretion, UAER),Masson染色觀察各組腎髒病理,Western Blot檢測PDGF、PDGFR蛋白錶達水平。結果與空白組比較,模型組24小時UAER明顯升高(P<0.05),腎組織PDGF、PDGFR蛋白錶達明顯升高;與模型組比較,纈沙坦組和糖腎寧組24小時UAER均有不同程度的降低(P<0.05),給藥組間無顯著性差異(P>0.05),腎組織PDGF、PDGFR蛋白錶達有不同程度降低(P<0.05)。結論糖腎寧能夠降低自髮性2型糖尿病KK-Ay小鼠24小時UAER,抑製PDGF及PDGFR蛋白的過度錶達,保護腎功能。
목적:관찰당신저대자발성2형당뇨병 KK-Ay소서신조직혈소판연생생장인자( platelet-derived growth factor, PDGF )、혈소판연생생장인자수체( platelet-derived growth factor receptor,PDGFR)단백표체적영향。방법채용자발성2형당뇨병KK-Ay소서건립당뇨병신병모형,수궤분위모형조、힐사탄조화당신저조각20지,설립C57BL/6J소서20지위공백조;약물간예12주후,측정24소시뇨미량백단백배설솔( urinary albumin excretion, UAER),Masson염색관찰각조신장병리,Western Blot검측PDGF、PDGFR단백표체수평。결과여공백조비교,모형조24소시UAER명현승고(P<0.05),신조직PDGF、PDGFR단백표체명현승고;여모형조비교,힐사탄조화당신저조24소시UAER균유불동정도적강저(P<0.05),급약조간무현저성차이(P>0.05),신조직PDGF、PDGFR단백표체유불동정도강저(P<0.05)。결론당신저능구강저자발성2형당뇨병KK-Ay소서24소시UAER,억제PDGF급PDGFR단백적과도표체,보호신공능。
Objective The aim of this study is to explore the effects of Tangshenning on renal function and expressions of Platelet-derived Growth Factor ( PDGF )、Platelet-derived Growth Factor Receptor ( PDGFR) on diabetic nephropathy mice model. Methods Spontaneous type 2 diabetic male KK -Ay mice were randomly divided into three groups:the model group (n=20),the valsartan group(n=20) and the Tangshenning group (n=20). Male C57BL/6J mice were chosen as control group (n=20). After 12 weeks of treatment with Tangshenning and valsartan, 24h Urinary albumin excretion (24h UAER) was examined and the expressions of PDGF,PDGFR were assessed by Western Blot. We also observed the renal pathological changes by Masson staining. Results Compared to that of in the control group, 24h UAER and the expressions of PDGF and PDGFR in the model group are significantly increased. Both treatment groups had significantly lower 24h UAER (P<0. 05) and PDGF and PDGFR protein expressions compared to the model group. Conclusion Tangshenning can protect renal function and decrease 24h UAER, which may due to the inhibition of PDGF and PDGFR protein expressions.